• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global DNA Sequencing Equipment and Services Market 2012-2016 Product Image

Global DNA Sequencing Equipment and Services Market 2012-2016

  • ID: 2617693
  • July 2013
  • Region: Global
  • 64 Pages
  • TechNavio

FEATURED COMPANIES

  • 23andMe Inc.
  • Asuragen Inc.
  • DNA Electronics Ltd.
  • GATC Biotech AG
  • Good Start Genetics Inc.
  • Macrogen Inc.
  • MORE

The analysts forecast the Global DNA Sequencing Equipment and Services market to grow at a CAGR of 20.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant advancements witnessed in R&D divisions. The Global DNA Sequencing Equipment and Services market has also been witnessing an increasing number of DNA sequencing projects. However, difficulties faced by small vendors could pose a challenge to the growth of this market.

The report, the Global DNA Sequencing Equipment and Services Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, the EMEA and APAC regions; it also covers the Global DNA Sequencing Equipment and Services market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Agilent Technologies Inc., Illumina Inc., Life Technologies Corp., Pacific Biosciences of California Inc., and Roche Holding AG.

The other vendors mentioned in this report are 23andMe Inc., Accelrys READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 23andMe Inc.
  • Asuragen Inc.
  • DNA Electronics Ltd.
  • GATC Biotech AG
  • Good Start Genetics Inc.
  • Macrogen Inc.
  • MORE

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Global DNA Sequencing Equipment and Services Market
Market Size and Forecast
06.2 Market Segmentation by Category
06.3 Global Sequencing Products and Consumables Market
Market Size and Forecast
06.4 Global Sequencing Services Market
Market Size and Forecast
06.5 Five Forces Analysis
07. Geographical Segmentation
08. Key Leading Countries
USA
Japan
Germany
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 Agilent Technologies Inc.
Business Overview
Key Information
SWOT Analysis
16.2 Illumina Inc.
Business Overview
Key Information
SWOT Analysis
16.3 Life Technologies Corp.
Business Overview
Key Information
SWOT Analysis
16.4 Pacific Biosciences of California Inc.
Business Overview
Key Information
SWOT Analysis
16.5 Roche Holding AG
Business Overview
Key Information
SWOT Analysis
17. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global DNA Sequencing Equipment and Services Market by Category
Exhibit 3: Global DNA Sequencing Equipment and Services Market 2012-2016 (US$ billion)
Exhibit 4: Global DNA Sequencing Equipment and Services Market by Category
Exhibit 5: Segmentation of Global DNA Sequencing Equipment and Services Market by Category 2012
Exhibit 6: Segmentation of Global DNA Sequencing Equipment and Services Market by Category 2012-2016 (US$ billion)
Exhibit 7: Segmentation of Global DNA Sequencing Equipment and Services Market by Category 2012-2016 (percentage)
Exhibit 8: Global Sequencing Products and Consumables Market 2012-2016 (US$ billion)
Exhibit 9: Global Sequencing Services Market 2012-2016 (US$ billion)
Exhibit 10: Global DNA Sequencing Equipment and Services Market by Geographical Segmentation 2012
Exhibit 11: Global DNA Sequencing Equipment and Services Market by Vendor Segmentation 2012
Exhibit 12: Business Segmentation of Agilent Technologies Inc.
Exhibit 13: Business Segmentation of Illumina Inc.
Exhibit 14: Business Segmentation of Life Technologies Corp.
Exhibit 15: Business Segmentation of Pacific Biosciences of California Inc.
Exhibit 16: Business Segmentation of Roche Holding AG
Exhibit 17: Roche Pharmaceuticals Segment Sale in FY2012
Exhibit 18: Roche Diagnostics Segment Sale in FY2012

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 23andMe Inc.
  • Asuragen Inc.
  • DNA Electronics Ltd.
  • GATC Biotech AG
  • Good Start Genetics Inc.
  • Macrogen Inc.
  • MORE

Commenting on the report, an analyst from the team said: “One of the main trends witnessed in the Global DNA Sequencing Equipment and Services market is increase in number of DNA sequencing projects. The Global DNA Sequencing Equipment and Services market has recently witnessed a significant increase in the number of projects funded by the leading vendors. For instance, Illumina and Partners HealthCare System Inc. announced a strategic alliance in September 2012, in order to offer infrastructure and networking tools for the interpretation and reporting process on genetic sequencing data. Moreover, Hoffmann-La Roche Ltd. and SoftGenetics LLC signed a co-promotion agreement in May 2012 for a new sequencing software tool. Roche and PerkinElmer Inc. announced a new supply agreement in May 2011 for the distribution of the NimbleGen CGX microarray workflow. In addition, Pacific Biosciences announced collaboration in July 2012, with Imec, a Belgium-based nanoelectronics research center focusing on the improvement of innovative microchips for multiplexed single-molecule genetic analysis.”

According to the report, one of the main factors driving the market is success of HGP. The HGP is an international scientific research project to regulate DNA sequences of the human body and to map the genes. The success of the HGP has led to a better understanding of human evolution. The effect of the HGP can help in the genotyping of specific viruses to direct suitable cure, identification of oncogenes and mutations in cancer, development of forensic applied sciences, and risk valuation.

Further, the report states that one of the main challenges is low adoption of genomic technology. Adoption of genomic technology remains low compared to other sequence analysis technologies, especially among large biotechnology companies. Researchers still have doubts over the advantages of genomic technology, mainly because of a few instances of failure during genomic research programs.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are 23andMe Inc., Accelrys Inc., AltheaDx Inc., Ambry Genetics Corp., Asuragen Inc., Base4 Innovation Ltd., BGI, Biomatters Ltd., BioNano Genomics Inc., Biotique Systems Inc., Danaher Corp., DNA Electronics Ltd., DNAnexus Inc., DNASTAR Inc., DNAVision SA, Eurofins Scientific SA, Fluidigm Corp., Foundation Medicine Inc., GATC Biotech AG, GE Healthcare Ltd., GenapSys Inc., Genia Corp., Genomatix Software GmbH, GenomeQuest Inc., Genomic Health Inc., Good Start Genetics Inc., HelicosBioSciences Corp., IBM Corp., IntegenX Inc., Knome Inc., Laboratory Corp. of America Holdings, Macrogen Inc., Oxford Nanopore Technologies Ltd., PerkinElmer Inc., QIAGEN N.V., RainDance Technologies Inc., Sequenom Inc., Siemens Healthcare, Source BioScience plc, TheragenEtex Co. Ltd., Transgenomic Inc., and Trovagene Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown

- Agilent Technologies Inc.
- Illumina Inc.
- Life Technologies Corp.
- Pacific Biosciences of California Inc.
- and Roche Holding AG.
- 23andMe Inc.
- Accelrys Inc.
- AltheaDx Inc.
- Ambry Genetics Corp.
- Asuragen Inc.
- Base4 Innovation Ltd.
- BGI
- Biomatters Ltd.
- BioNano Genomics Inc.
- Biotique Systems Inc.
- Danaher Corp.
- DNA Electronics Ltd.
- DNAnexus Inc.
- DNASTAR Inc.
- DNAVision SA
- Eurofins Scientific SA
- Fluidigm Corp.
- Foundation Medicine Inc.
- GATC Biotech AG
- GE Healthcare Ltd.
- GenapSys Inc.
- Genia Corp.
- Genomatix Software GmbH
- GenomeQuest Inc.
- Genomic Health Inc.
- Good Start Genetics Inc.
- HelicosBioSciences Corp.
- IBM Corp.
- IntegenX Inc.
- Knome Inc.
- Laboratory Corp. of America Holdings
- Macrogen Inc.
- Oxford Nanopore Technologies Ltd.
- PerkinElmer Inc.
- QIAGEN N.V.
- RainDance Technologies Inc.
- Sequenom Inc.
- Siemens Healthcare
- Source BioScience plc
- TheragenEtex Co. Ltd.
- Transgenomic Inc.
- and Trovagene Inc..

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos